HIV Seroprevalence among Women Opting Out of Prenatal HIV Screening in Alberta, Canada: 2002-2004 | Zendy

Sabrina S. Plitt | Zendy; Ameeta E. Singh | Zendy; B. E. Lee | Zendy; Jutta K. Preiksaitis | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

HIV Seroprevalence among Women Opting Out of Prenatal HIV Screening in Alberta, Canada: 2002-2004

Author(s) -

Sabrina S. Plitt,

Ameeta E. Singh,

B. E. Lee,

Jutta K. Preiksaitis

Publication year - 2007

Publication title -

clinical infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 3.44

H-Index - 336

eISSN - 1537-6591

pISSN - 1058-4838

DOI - 10.1086/523730

Subject(s) - seroprevalence , medicine , human immunodeficiency virus (hiv) , opting out , sida , demography , obstetrics , immunology , viral disease , antibody , serology , sociology , economics , keynesian economics

Alberta, Canada, uses an "opt-out" strategy for prenatal HIV testing. We examined demographic characteristics of and HIV seroprevalence among women opting out. The proportion of total specimens that were from women who opted out decreased from 4.3% in 2002 to 3.6% in 2004 (P<.001), and HIV seroprevalence among these specimens was 0.07%, which was 3.3 times higher than the HIV seroprevalence among specimens from women who opted in. Women opting out may have a higher HIV infection risk.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research